Obtenez 3 mois à 0,99 $/mois

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Let's talk F*ng Cancer

Let's talk F*ng Cancer

Let's talk F*ng Cancer

Auteur(s): Colette Hoang
Écouter gratuitement

À propos de cet audio

Welcome to the Let's Talk F*ng Cancer podcast. Where we will be covering all things in the cancer world. With our 4 monthly topics covering professionals from the cancer world, tips& tricks to get through your chemotherapy, radiation and more. We will also be having spotlight episodes speaking with cancer survivors and thrivers, as well as a grief and remembrance segment focusing on saying the names of loved ones passed.Copyright 2025 Colette Hoang Hygiène et mode de vie sain Médecine alternative Psychologie Psychologie et santé mentale Troubles et maladies
Épisodes
  • Ep. 86 - November "What's New" in cancer news and research AND Congratulations Julia and Matt!
    Nov 21 2025

    In this month’s “What’s New” episode, we kick things off with some joy — catching up on life, sharing big updates, and celebrating JULIA AND MATT GETTING MARRIED! 🥂✨

    From there, we dive into the latest breakthroughs happening across the cancer research world. Each of us covers a different area of emerging science, treatment advancement, or clinical insight — and as always, we break it down in a way that’s real, relatable, and rooted in hope. 🧬 Julia: Understanding Carcinoid Tumors, 💨 Leah: How Far Lung Cancer Treatment Has Come — Especially in the Last 2 Years, 🔬 Colette: Pancreatic Cancer Breakthrough — Cryptic Peptides Reveal New Targets

    Sources Below:

    Mayo Clinic Carcinoid Tumors

    Cleveland Clinic Neuroendocrine Tumors

    AACR Old New Borrowed and Blue, approaches for non small cell carcinoma

    The Lancet - Lung cancer treatment: 20 years of progress

    Pancreatic Cancer Breathrough

    The full research paper is titled:

    “Pancreatic cancer–restricted cryptic antigens are targets for T cell immunotherapy.”

    Published in Science.

    DOI: 10.1126/science.adk3487

    Lead authors: Zackery Ely and Zachary Kulstad

    Senior authors: Tyler Jacks and William Freed-Pastor

    This was summarized in the MIT News article:

    “Biologists identify targets for new pancreatic cancer treatments”

    Written by Anne Trafton

    Published May 8, 2025

    Voir plus Voir moins
    44 min
  • Ep. 85 Cara Lockwood bestselling author and cancer survivor
    Oct 28 2025

    When bestselling author Cara Lockwood was diagnosed with Stage 1 breast cancer in 2023, she didn’t look for inspiration in solemn pamphlets or dusty medical books. She looked for laughter, swearing, and straight talk — the kind of encouragement you get from your funniest, most unfiltered friend. In "There’s No Good Book for This but I Wrote One Anyway: The Irreverent Guide to Crushing Breast Cancer" (Oct. 1, 2025), Cara shares the gritty, absurd, and often hilarious truth about treatment, recovery, and life after a double mastectomy, chemo, and reconstruction.

    Part Memoir. Part Pep Talk. Part Screaming Into the Void.

    For Patients, Survivors, and the People Who Love Them

    Laugh, Cry, and Then Laugh Again

    Fighting for a Cure — One Book at a Time

    Get your copy Below:

    https://caratanamachi.com/no-good-book-for-this

    https://caratheauthor.com/

    Find Cara on Social Media

    https://www.instagram.com/cara.the.author/

    https://www.facebook.com/AuthorCaraLockwood/

    https://www.linkedin.com/in/cara-lockwood-563b5040/

    https://www.tiktok.com/@caratanamachi

    Voir plus Voir moins
    53 min
  • Ep. 84 - "Whats New In Cancer News and Research" September Childhood cancer, Blood cancer, Thyroid cancer, Ovarian and Gynecological cancers
    Oct 1 2025

    🌟 September is HUGE for cancer awareness 🌟

    This month shines the spotlight on:

    🩸 Blood cancers

    🎗️ Childhood cancer

    🌸 Gynecologic & ovarian cancers

    👨 Prostate cancer

    🦋 Thyroid cancer

    In my latest What’s New solo episode, I’m diving into:

    ✅ Breakthrough drugs giving blood cancer patients longer remissions

    ✅ A 12-year-old’s inspiring story of targeted therapy success

    ✅ CAR-T therapies expanding into ovarian cancer

    ✅ New prostate cancer screening guidelines

    ✅ The rise of precision medicine & theranostics

    ✅ Futuristic innovations like synthetic drug factories inside the body 🤯

    💪 Research is moving fast, and awareness saves lives. Tune in to learn, get inspired, and spread the hope.#LetsTalkFnCancer #CancerAwarenessMonth #CancerResearch #Podcast #CancerBreakthroughs

    sources:

    Highlights in this episode:
    • Blood cancers: Eli Lilly’s Jaypirca helps CLL/SLL patients live longer without progression; CAR-T therapy delivers remission for aggressive lymphoma 【web†source】.
    • Childhood cancer: A 12-year-old’s brain tumor stabilized after a targeted melanoma drug via the ZERO program in Sydney 【web†source】.
    • Gynecologic & ovarian cancers: CAR-T therapy expands into solid tumors; Eli-002 cancer vaccine shows strong KRAS-targeted immune responses 【web†source】.
    • Prostate cancer: Proposed guidelines could lower PSA screening age to 40, paired with MRI for more precise detection 【web†source】.
    • Thyroid cancer: Theranostics—blending diagnostics and therapy—emerges as a precision medicine frontier 【web†source】.
    • Broader innovations: New immunotherapies, remote clinical trials, synthetic drug factories, and research to prevent recurrence in breast cancer 【web†source】.

    Sources:
    • Reuters — Lilly’s blood cancer drug meets main goal in late-stage study
    • Daily Telegraph — 12-year-old Sydney boy’s inspiring brain tumour journey
    • Fraunhofer — CAR-T cells fight solid tumors
    • New York Post — Cancer vaccine may prevent recurrence of pancreatic/colorectal tumors
    • The Australian — Prostate cancer guideline update
    • Wikipedia — Theranostics overview
    • Reuters — BioNTech/Bristol Myers immunotherapy trial
    • Cure Today — New clinical trials launch as cancer studies advance
    • The Times —
    Voir plus Voir moins
    28 min
Pas encore de commentaire